-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Rubius Therapeutics, Inc. annual/quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2022.
- Rubius Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 90.4M shares, a 0.62% increase year-over-year.
- Rubius Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 90.3M shares, a 2.68% increase from 2021.
- Rubius Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 88M shares, a 9.09% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)